Cargando…
Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea
BACKGROUND: Systemic lupus erythematosus (SLE) poses a growing challenge for healthcare systems, affecting an increasing number of people in Korea. This study aimed to investigate the prescribing patterns of SLE therapies and to compare common drug regimens prescribed by provider types. METHODS: Sam...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652906/ https://www.ncbi.nlm.nih.gov/pubmed/29081653 http://dx.doi.org/10.2147/PPA.S146119 |
_version_ | 1783273148873965568 |
---|---|
author | Shin, Sooyoung |
author_facet | Shin, Sooyoung |
author_sort | Shin, Sooyoung |
collection | PubMed |
description | BACKGROUND: Systemic lupus erythematosus (SLE) poses a growing challenge for healthcare systems, affecting an increasing number of people in Korea. This study aimed to investigate the prescribing patterns of SLE therapies and to compare common drug regimens prescribed by provider types. METHODS: Sampled national health insurance claims data in 2015 were used to select eligible SLE patients. Frequency analyses were carried out regarding patient characteristics related to relevant SLE prescriptions. Patient-days were calculated per substance and per drug class and then categorized by provider types. Differences in drug utilization trends among the main types of providers were examined with the chi-square test. RESULTS: A total of 2,074 patients with SLE were selected for study inclusion. Systemic corticosteroid therapy was provided for up to 67.9% of patients, frequently in conjunction with other SLE therapies. About 33.2% and 18.7% of steroid users were treated for more than 150 days and 300 days during the study period, respectively. The provider group that most frequently prescribed systemic corticosteroids was dermatologists. Hydroxychloroquine, an antimalarial considered pivotal to SLE management, was prescribed for only 32.4% of patients, predominantly by rheumatologists. Antimalarial therapy was associated with the longest therapy duration (257.7±120.1 days), followed by immunosuppressant therapy (187.0±153.0 days). Prescription rates of antimalarials and immunosuppressants were substantially lower in primary care doctor group and particularly in dermatologist group, compared to rheumatologist group (P-value associated with prescription patterns by provider types was <0.001 for both drug classes). CONCLUSION: The drug utilization patterns among the main provider groups commonly providing care for SLE patients differed significantly depending on their practice areas. The prescription rates of corticosteroids were disproportionately higher among dermatologists. Rheumatologists appeared more cognizant of the importance of providing antimalarial therapy for SLE patients compared to other types of providers. |
format | Online Article Text |
id | pubmed-5652906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56529062017-10-27 Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea Shin, Sooyoung Patient Prefer Adherence Original Research BACKGROUND: Systemic lupus erythematosus (SLE) poses a growing challenge for healthcare systems, affecting an increasing number of people in Korea. This study aimed to investigate the prescribing patterns of SLE therapies and to compare common drug regimens prescribed by provider types. METHODS: Sampled national health insurance claims data in 2015 were used to select eligible SLE patients. Frequency analyses were carried out regarding patient characteristics related to relevant SLE prescriptions. Patient-days were calculated per substance and per drug class and then categorized by provider types. Differences in drug utilization trends among the main types of providers were examined with the chi-square test. RESULTS: A total of 2,074 patients with SLE were selected for study inclusion. Systemic corticosteroid therapy was provided for up to 67.9% of patients, frequently in conjunction with other SLE therapies. About 33.2% and 18.7% of steroid users were treated for more than 150 days and 300 days during the study period, respectively. The provider group that most frequently prescribed systemic corticosteroids was dermatologists. Hydroxychloroquine, an antimalarial considered pivotal to SLE management, was prescribed for only 32.4% of patients, predominantly by rheumatologists. Antimalarial therapy was associated with the longest therapy duration (257.7±120.1 days), followed by immunosuppressant therapy (187.0±153.0 days). Prescription rates of antimalarials and immunosuppressants were substantially lower in primary care doctor group and particularly in dermatologist group, compared to rheumatologist group (P-value associated with prescription patterns by provider types was <0.001 for both drug classes). CONCLUSION: The drug utilization patterns among the main provider groups commonly providing care for SLE patients differed significantly depending on their practice areas. The prescription rates of corticosteroids were disproportionately higher among dermatologists. Rheumatologists appeared more cognizant of the importance of providing antimalarial therapy for SLE patients compared to other types of providers. Dove Medical Press 2017-10-17 /pmc/articles/PMC5652906/ /pubmed/29081653 http://dx.doi.org/10.2147/PPA.S146119 Text en © 2017 Shin. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Shin, Sooyoung Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea |
title | Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea |
title_full | Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea |
title_fullStr | Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea |
title_full_unstemmed | Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea |
title_short | Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea |
title_sort | drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in korea |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652906/ https://www.ncbi.nlm.nih.gov/pubmed/29081653 http://dx.doi.org/10.2147/PPA.S146119 |
work_keys_str_mv | AT shinsooyoung drugutilizationandtherapyprovisionpatternsbyprescribertypesamongpatientswithsystemiclupuserythematosusinkorea |